Aytu BioPharma is a specialty pharmaceutical company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on hypogonadism, prostate cancer, male infertility, and plans to expand into other urological indications for which there are significant medical needs. The company was formed as a result of a merger between Neos Therapeutics and Aytu BioScience.